Pantanetti P, Ronconi V, Sguanci M, Palomares SM, Mancin S, Tartaglia FC, et al
FDA Advisory Panel Votes to Loosen Rules on BPC-157, TB-500, and MOTS-C Despite Agency Scientists' Opposition An FDA advisory committee voted narrowly on July 23, 2026, to recommend that compounding pharmacies gain access to several popular peptide compounds, including BPC-157, KPV, TB-500, and MOTS-C, overriding explicit objections from the FDA's own career scientists and sparking an audible gasp in the meeting room when the tally was announced
The best place to inject tirzepatide is one of the three recommended injection sites: Abdomen Front, outer thigh Upper arm (if someone is helping you) If youre self-injecting, its best to choose your stomach (at least 2 inches away from your belly button) or the front part of your outer thigh
OTC options produce roughly 3 to 5 percent body weight loss on average, while prescription GLP-1 medications and bariatric surgery produce 15 to 30 percent or more